Keywords: crt, enters, colorectal, cancer, accord, astrazeneca, research

CRT enters colorectal cancer R&D accord with AstraZeneca

Article | 11 September 2006

Cancer Research Technology, an oncology-focused development and commercialization company wholly owned by the charity Cancer Research UK, says it has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in